THE OLD MUTUAL GLOBAL INVESTORS UK LTD. INVESTS $901,000 IN ANIKA THERAPEUTICS INC. (ANIK)

Old Mutual Global Investors UK Ltd. purchased a new position in Anika Therapeutics Inc. (NASDAQ:ANIK) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 18,841 shares of the company’s stock, valued at approximately $901,000. Old Mutual Global Investors UK Ltd. owned about 0.13% of Anika Therapeutics at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Chicago Equity Partners LLC acquired a new position in shares of Anika Therapeutics during the third quarter worth about $294,000. Texas Permanent School Fund raised its position in shares of Anika Therapeutics by 2.7% in the third quarter. Texas Permanent School Fund now owns 11,258 shares of the company’s stock worth $539,000 after buying an additional 300 shares during the period. Great West Life Assurance Co. Can raised its position in shares of Anika Therapeutics by 7.3% in the third quarter. Great West Life Assurance Co. Can now owns 20,075 shares of the company’s stock worth $960,000 after buying an additional 1,366 shares during the period. HL Financial Services LLC raised its position in shares of Anika Therapeutics by 23.4% in the third quarter. HL Financial Services LLC now owns 57,551 shares of the company’s stock worth $2,754,000 after buying an additional 10,920 shares during the period. Finally, Louisiana State Employees Retirement System raised its position in shares of Anika Therapeutics by 3.2% in the third quarter. Louisiana State Employees Retirement System now owns 6,500 shares of the company’s stock worth $311,000 after buying an additional 200 shares during the period. Institutional investors own 76.01% of the company’s stock.
OrthoSpineNews
OrthoSpineNews.com is the preferred aggregator of all news in the orthopedic and spine industry. You can subscribe for our daily email, follow us on twitter or download our app for iPhone and Android.